{"id":1517,"date":"2021-06-21T16:07:47","date_gmt":"2021-06-21T14:07:47","guid":{"rendered":"https:\/\/hemerion.com\/solutions-therapeutiques\/cancer-du-cerveau-et-glioblastome\/"},"modified":"2025-11-04T15:02:26","modified_gmt":"2025-11-04T14:02:26","slug":"cancer-du-cerveau-et-glioblastome","status":"publish","type":"page","link":"https:\/\/hemerion.com\/fr\/solutions-therapeutiques\/cancer-du-cerveau-et-glioblastome\/","title":{"rendered":"Cancer du Cerveau et Glioblastome"},"content":{"rendered":"<div class=\"gb-container gb-container-950d408f\"><div class=\"gb-inside-container\">\n\n<p class=\"gb-headline gb-headline-e55584b8 gb-headline-text lead\">Le <strong>glioblastome<\/strong> (GBM) est <strong>la tumeur c\u00e9r\u00e9brale primaire la plus fr\u00e9quente et la plus agressive<\/strong>, avec une survie globale (OS) m\u00e9diane de 15 mois et une survie sans progression (PFS) de 7 mois seulement. Les traitements actuels (chirurgie, puis radioth\u00e9rapie et chimioth\u00e9rapie) <strong>ralentissent la progression de la maladie et r\u00e9duisent les sympt\u00f4mes, mais n&rsquo;offrent pas de v\u00e9ritables solutions th\u00e9rapeutiques.<\/strong><br><a href=\"https:\/\/hemerion.com\/fr\/solutions-therapeutiques\/\">Les technologies d&rsquo;Hemerion<\/a> visent \u00e0 am\u00e9liorer l&rsquo;efficacit\u00e9 de la chirurgie, \u00e0 prolonger consid\u00e9rablement la survie et \u00e0 am\u00e9liorer la qualit\u00e9 de vie des patients atteints de glioblastome.<\/p>\n\n<\/div><\/div><div class=\"gb-container gb-container-064e3afa\"><div class=\"gb-inside-container\">\n<div class=\"gb-grid-wrapper gb-grid-wrapper-000152a1 mosaic-section text-left\">\n<div class=\"gb-grid-column gb-grid-column-4946e619\"><div class=\"gb-container gb-container-4946e619 hgsap fromLeft\"><div class=\"gb-inside-container\">\n\n<h2 class=\"gb-headline gb-headline-6123d41c gb-headline-text\"><mark class=\"gb-highlight\">Une maladie d\u00e9vastatrice<\/mark><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Le <strong>glioblastome<\/strong>, \u00e9galement appel\u00e9 glioblastome multiforme (<strong>GBM<\/strong>), est un gliome \u00e0 croissance rapide qui se d\u00e9veloppe \u00e0 partir de cellules gliales en forme d&rsquo;\u00e9toile (astrocytes et oligodendrocytes). Le GBM est souvent d\u00e9sign\u00e9 comme un astrocytome de grade IV.<br\/>Les GBM peuvent se d\u00e9velopper \u00ab\u00a0de novo\u00a0\u00bb ou \u00e9voluer \u00e0 partir d&rsquo;astrocytomes ou d&rsquo;oligodendrogliomes de grade inf\u00e9rieur.<br\/>Ils surviennent principalement dans les h\u00e9misph\u00e8res c\u00e9r\u00e9braux, en particulier <strong>dans les lobes frontaux et temporaux<\/strong>.<br\/>Les <strong>GBMs<\/strong> doublent de taille tous les mois s&rsquo;ils ne sont pas trait\u00e9s: ce sont les <strong>tumeurs primaires du cerveau les plus agressives<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">La plupart des patients atteints de <strong>glioblastome<\/strong> pr\u00e9sentent g\u00e9n\u00e9ralement une histoire clinique courte, allant de 3 \u00e0 6 mois :<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>La n\u00e9crose et la destruction du tissu c\u00e9r\u00e9bral entra\u00eenent un d\u00e9ficit neuronal focal et des troubles cognitifs, selon les r\u00e9gions touch\u00e9es par la tumeur.<\/li>\n\n\n\n<li>L&rsquo;augmentation de la pression intracr\u00e2nienne due \u00e0 l&rsquo;augmentation de la taille de la tumeur et l&rsquo;\u0153d\u00e8me entra\u00eenent des maux de t\u00eate d&rsquo;intensit\u00e9 progressive.<\/li>\n\n\n\n<li>Les crises d&rsquo;\u00e9pilepsie affectent 20 \u00e0 40 % des patients et peuvent \u00eatre partielles, partielles complexes ou g\u00e9n\u00e9ralis\u00e9es.<\/li>\n<\/ul>\n\n<\/div><\/div><\/div>\n\n<div class=\"gb-grid-column gb-grid-column-51a1ab06\"><div class=\"gb-container gb-container-51a1ab06  hgsap fromRight\"><div class=\"gb-inside-container\">\n\n<figure class=\"wp-block-image size-large\"><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"682\" src=\"https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/\/doctor-examining-scans.jpg?resize=1024%2C682&#038;ssl=1\" alt=\"M&#xE9;decin examinant des scanners\" class=\"wp-image-882\" srcset=\"https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/doctor-examining-scans.jpg?resize=1024%2C682&amp;ssl=1 1024w, https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/doctor-examining-scans.jpg?resize=300%2C200&amp;ssl=1 300w, https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/doctor-examining-scans.jpg?resize=768%2C512&amp;ssl=1 768w, https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/doctor-examining-scans.jpg?resize=1536%2C1024&amp;ssl=1 1536w, https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/doctor-examining-scans.jpg?resize=1200%2C800&amp;ssl=1 1200w, https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/doctor-examining-scans.jpg?w=2000&amp;ssl=1 2000w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n<\/div><\/div><\/div>\n<\/div>\n<\/div><\/div><div class=\"gb-container gb-container-3cb92d7a\"><div class=\"gb-inside-container\">\n<div class=\"gb-grid-wrapper gb-grid-wrapper-a25a3470 mosaic-section\">\n<div class=\"gb-grid-column gb-grid-column-72257501\"><div class=\"gb-container gb-container-72257501 hgsap fromLeft\"><div class=\"gb-inside-container\">\n\n<figure class=\"wp-block-image size-large\"><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"682\" src=\"https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/\/brain-x-rays.jpg?resize=1024%2C682&#038;ssl=1\" alt=\"Radiologie du cerveau\" class=\"wp-image-884\" srcset=\"https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/brain-x-rays.jpg?resize=1024%2C682&amp;ssl=1 1024w, https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/brain-x-rays.jpg?resize=300%2C200&amp;ssl=1 300w, https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/brain-x-rays.jpg?resize=768%2C512&amp;ssl=1 768w, https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/brain-x-rays.jpg?resize=1536%2C1024&amp;ssl=1 1536w, https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/brain-x-rays.jpg?resize=1200%2C800&amp;ssl=1 1200w, https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/brain-x-rays.jpg?w=2000&amp;ssl=1 2000w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n<\/div><\/div><\/div>\n\n<div class=\"gb-grid-column gb-grid-column-1502fbf7\"><div class=\"gb-container gb-container-1502fbf7  hgsap fromRight\"><div class=\"gb-inside-container\">\n\n<h2 class=\"gb-headline gb-headline-f1e3a9a4 gb-headline-text\"><mark class=\"gb-highlight\">Un d\u00e9fi mondial de sant\u00e9 publique<\/mark><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Avec une incidence mondiale de 2 \u00e0 5 pour 100 000 personnes et un pronostic tr\u00e8s d\u00e9favorable (la dur\u00e9e de survie apr\u00e8s le diagnostic est d&rsquo;environ 17 mois), le <strong>glioblastome (GBM)<\/strong> est un probl\u00e8me majeur de sant\u00e9 publique.<br\/><strong>Le GBM<\/strong> repr\u00e9sente 50 % de tous les gliomes dans toutes les tranches d&rsquo;\u00e2ge, avec un pic d&rsquo;incidence entre 55 et <sup>611<\/sup>.<br\/>47 000 patients par an en Europe et aux \u00c9tats-Unis sont nouvellement diagnostiqu\u00e9s porteurs d&rsquo;un GBM.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><sup>1<\/sup><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5563115\/\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5563115\/<\/a><\/p>\n\n<\/div><\/div><\/div>\n<\/div>\n<\/div><\/div><div class=\"gb-container gb-container-391135e8\"><div class=\"gb-inside-container\">\n<div class=\"gb-grid-wrapper gb-grid-wrapper-6db843cf mosaic-section text-left\">\n<div class=\"gb-grid-column gb-grid-column-44181b98\"><div class=\"gb-container gb-container-44181b98 hgsap fromLeft\"><div class=\"gb-inside-container\">\n\n<h2 class=\"gb-headline gb-headline-b1a37ffd gb-headline-text\"><mark class=\"gb-highlight\">Un besoin m\u00e9dical non satisfait<\/mark><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Depuis 2005, la norme de soins n&rsquo;a pas chang\u00e9 et<strong> peu d&rsquo;innovations ont \u00e9t\u00e9 propos\u00e9es aux patients<\/strong> souffrant de cette pathologie.<br\/>Le principal traitement des glioblastomes est la <strong>chirurgie<\/strong>, suivie d&rsquo;une <strong>radioth\u00e9rapie<\/strong> et d&rsquo;une <strong>chimioth\u00e9rapie<\/strong>.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>L&rsquo;objectif primaire de la chirurgie est de retirer le maximum de la tumeur sans endommager le tissu c\u00e9r\u00e9bral sain environnant. Cependant, les <strong>cellules tumorales du GBM<\/strong> migrent et s&rsquo;infiltrent profond\u00e9ment dans les tissus environnants, ce qui rend impossible <strong>l&rsquo;\u00e9limination compl\u00e8te de la tumeur<\/strong>. Cette limitation ouvre la voie \u00e0 d&rsquo;in\u00e9luctables <strong>r\u00e9cidives.<\/strong><\/li>\n\n\n\n<li>La radioth\u00e9rapie est g\u00e9n\u00e9ralement effectu\u00e9e apr\u00e8s la chirurgie pour <strong>tuer les cellules tumorales restantes mais cela au d\u00e9triment des tissus sains.<\/strong><\/li>\n\n\n\n<li>La chimioth\u00e9rapie avec le Temozolomide est la norme actuelle de traitement des <strong>GBM<\/strong>. Le m\u00e9dicament est administr\u00e9 tous les jours pendant la radioth\u00e9rapie, puis pendant 6 \u00e0 12 cycles de 5 jours apr\u00e8s celle-ci. <strong>La chimioth\u00e9rapie vise \u00e0 contr\u00f4ler la tumeur \u00e0 long terme mais cela ne r\u00e9ussit que dans 20 % des cas.<\/strong><\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">La radioth\u00e9rapie et la chimioth\u00e9rapie effectu\u00e9es apr\u00e8s la chirurgie ne permettent qu&rsquo;une prolongation modeste de la survie sans progression. Les th\u00e9rapies les plus efficaces utilis\u00e9es au cours des 30 derni\u00e8res ann\u00e9es n&rsquo;ont am\u00e9lior\u00e9 la survie m\u00e9diane que de 3 mois en <sup>moyenne2<\/sup>.<br\/>L&rsquo;approche th\u00e9rapeutique d&rsquo;Hemerion vise \u00e0 am\u00e9liorer de mani\u00e8re significative ces r\u00e9sultats et \u00e0 s&rsquo;int\u00e9grer rapidement dans la norme de soins.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><sup>2<\/sup><a href=\"https:\/\/www.aans.org\/en\/Patients\/Neurosurgical-Conditions-and-Treatments\/Glioblastoma-Multiforme\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/www.aans.org\/en\/Patients\/Neurosurgical-Conditions-and-Treatments\/Glioblastoma-Multiforme<\/a><\/p>\n\n<\/div><\/div><\/div>\n\n<div class=\"gb-grid-column gb-grid-column-bed71815\"><div class=\"gb-container gb-container-bed71815  hgsap fromRight\"><div class=\"gb-inside-container\">\n\n<figure class=\"wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio\"><div class=\"wp-block-embed__wrapper\">\n<span class=\"embed-youtube\" style=\"text-align:center; display: block;\"><iframe loading=\"lazy\" class=\"youtube-player\" width=\"1200\" height=\"675\" src=\"https:\/\/www.youtube.com\/embed\/lnFc4UtXbAY?version=3&#038;rel=0&#038;showsearch=0&#038;showinfo=1&#038;iv_load_policy=1&#038;fs=1&#038;hl=fr-FR&#038;autohide=2&#038;wmode=transparent\" allowfullscreen=\"true\" style=\"border:0;\" sandbox=\"allow-scripts allow-same-origin allow-popups allow-presentation allow-popups-to-escape-sandbox\"><\/iframe><\/span>\n<\/div><\/figure>\n\n\n\n<div style=\"height:40px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<figure class=\"wp-block-image size-large\"><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"682\" src=\"https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/\/cancer-patient.jpg?resize=1024%2C682&#038;ssl=1\" alt=\"Patient atteint d'un cancer\" class=\"wp-image-885\" srcset=\"https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/cancer-patient.jpg?resize=1024%2C682&amp;ssl=1 1024w, https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/cancer-patient.jpg?resize=300%2C200&amp;ssl=1 300w, https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/cancer-patient.jpg?resize=768%2C512&amp;ssl=1 768w, https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/cancer-patient.jpg?resize=1536%2C1024&amp;ssl=1 1536w, https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/cancer-patient.jpg?resize=1200%2C800&amp;ssl=1 1200w, https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/cancer-patient.jpg?w=2000&amp;ssl=1 2000w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n<\/div><\/div><\/div>\n<\/div>\n<\/div><\/div><div class=\"gb-button-wrapper gb-button-wrapper-ccf6ee64\">\n\n<a class=\"gb-button gb-button-1f241b82\" href=\"https:\/\/hemerion.com\/fr\/solutions-therapeutiques\/technologie\/\"><span class=\"gb-icon\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewbox=\"0 0 30 30\" height=\"30\" width=\"30\">   <g transform=\"translate(0.715 0.111)\" id=\"button-angle\">     <g fill=\"none\" transform=\"translate(-0.715 -0.111)\" data-name=\"Trac\u00e9 73\" id=\"Trac\u00e9_73\">       <path stroke=\"none\" d=\"M15,0A15,15,0,1,1,0,15,15,15,0,0,1,15,0Z\"><\/path>       <path fill=\"#fff\" stroke=\"none\" d=\"M 15 2 C 11.5275707244873 2 8.262990951538086 3.352239608764648 5.807609558105469 5.807609558105469 C 3.352239608764648 8.262990951538086 2 11.5275707244873 2 15 C 2 18.47243118286133 3.352239608764648 21.73701095581055 5.807609558105469 24.19239044189453 C 8.262990951538086 26.64776039123535 11.5275707244873 28 15 28 C 18.47243118286133 28 21.73701095581055 26.64776039123535 24.19239044189453 24.19239044189453 C 26.64776039123535 21.73701095581055 28 18.47243118286133 28 15 C 28 11.5275707244873 26.64776039123535 8.262990951538086 24.19239044189453 5.807609558105469 C 21.73701095581055 3.352239608764648 18.47243118286133 2 15 2 M 15 0 C 23.28426933288574 0 30 6.715730667114258 30 15 C 30 23.28426933288574 23.28426933288574 30 15 30 C 6.715730667114258 30 0 23.28426933288574 0 15 C 0 6.715730667114258 6.715730667114258 0 15 0 Z\"><\/path>     <\/g>     <path fill=\"#fff\" transform=\"translate(9.059 1.609)\" d=\"M9.893,13.98,4.337,19.536a.976.976,0,0,1-1.385,0l-.923-.923a.976.976,0,0,1,0-1.385L5.967,13.29,2.028,9.351a.976.976,0,0,1,0-1.385l.919-.932a.976.976,0,0,1,1.385,0l5.556,5.556A.978.978,0,0,1,9.893,13.98Z\" data-name=\"Icon awesome-angle-right\" id=\"Icon_awesome-angle-right\"><\/path>   <\/g> <\/svg><\/span><span class=\"gb-button-text\">En aprrendre plus sur <strong>notre technologie<\/strong><\/span><\/a>\n\n<\/div>\n<div style=\"height:40px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n<div class=\"gb-container gb-container-b3fa9579\"><div class=\"gb-inside-container\">\n<div class=\"gb-button-wrapper gb-button-wrapper-22f8a4af\">\n\n<a class=\"gb-button gb-button-fa0846ad\" href=\"https:\/\/hemerion.com\/fr\/solutions-therapeutiques\/\"><span class=\"gb-icon\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewbox=\"0 0 11.534 17.863\" height=\"17.863\" width=\"11.534\">   <path fill=\"#434342\" transform=\"translate(-1.734 -6.747)\" d=\"M2.127,14.729,9.716,7.14a1.334,1.334,0,0,1,1.892,0L12.869,8.4a1.334,1.334,0,0,1,0,1.892L7.5,15.678l5.38,5.38a1.334,1.334,0,0,1,0,1.892l-1.261,1.267a1.334,1.334,0,0,1-1.892,0L2.132,16.627a1.336,1.336,0,0,1-.006-1.9Z\" data-name=\"Icon awesome-angle-left\" id=\"Icon_awesome-angle-left\"><\/path> <\/svg><\/span><span class=\"gb-button-text\">Solutions Th\u00e9rapeutiques<\/span><\/a>\n\n<\/div>\n<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Le glioblastome (GBM) est la tumeur c\u00e9r\u00e9brale primaire la plus fr\u00e9quente et la plus agressive, avec une survie globale (OS) m\u00e9diane de 15 mois et une survie sans progression (PFS) de 7 mois seulement. Les traitements actuels (chirurgie, puis radioth\u00e9rapie et chimioth\u00e9rapie) ralentissent la progression de la maladie et r\u00e9duisent les sympt\u00f4mes, mais n&rsquo;offrent pas &#8230; <\/p>\n<p class=\"read-more-container\"><a title=\"Cancer du Cerveau et Glioblastome\" class=\"read-more button\" href=\"https:\/\/hemerion.com\/fr\/solutions-therapeutiques\/cancer-du-cerveau-et-glioblastome\/#more-1517\" aria-label=\"En savoir plus sur Cancer du Cerveau et Glioblastome\">Lire plus<\/a><\/p>\n","protected":false},"author":207845438,"featured_media":1321,"parent":1501,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","_crdt_document":"","jetpack_post_was_ever_published":false,"_jet_sm_ready_style":"","_jet_sm_style":"","_jet_sm_controls_values":"","_jet_sm_fonts_collection":"","_jet_sm_fonts_links":"","footnotes":""},"class_list":["post-1517","page","type-page","status-publish","has-post-thumbnail"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cancer du Cerveau et Glioblastome<\/title>\n<meta name=\"description\" content=\"Le glioblastome est le cancer le plus fr\u00e9quent et le plus agressif. Les traitements actuels ne font que ralentir la progression de la maladie.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/hemerion.com\/fr\/solutions-therapeutiques\/cancer-du-cerveau-et-glioblastome\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cancer du Cerveau et Glioblastome\" \/>\n<meta property=\"og:description\" content=\"Le glioblastome est le cancer le plus fr\u00e9quent et le plus agressif. Les traitements actuels ne font que ralentir la progression de la maladie.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/hemerion.com\/fr\/solutions-therapeutiques\/cancer-du-cerveau-et-glioblastome\/\" \/>\n<meta property=\"og:site_name\" content=\"Hemerion\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-04T14:02:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/medical-imaging.jpg?fit=2000%2C680&ssl=1\" \/>\n\t<meta property=\"og:image:width\" content=\"2000\" \/>\n\t<meta property=\"og:image:height\" content=\"680\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@HemerionTx\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/solutions-therapeutiques\\\/cancer-du-cerveau-et-glioblastome\\\/\",\"url\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/solutions-therapeutiques\\\/cancer-du-cerveau-et-glioblastome\\\/\",\"name\":\"Cancer du Cerveau et Glioblastome\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/solutions-therapeutiques\\\/cancer-du-cerveau-et-glioblastome\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/solutions-therapeutiques\\\/cancer-du-cerveau-et-glioblastome\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/hemerion.com\\\/wp-content\\\/uploads\\\/medical-imaging.jpg?fit=2000%2C680&ssl=1\",\"datePublished\":\"2021-06-21T14:07:47+00:00\",\"dateModified\":\"2025-11-04T14:02:26+00:00\",\"description\":\"Le glioblastome est le cancer le plus fr\u00e9quent et le plus agressif. Les traitements actuels ne font que ralentir la progression de la maladie.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/solutions-therapeutiques\\\/cancer-du-cerveau-et-glioblastome\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/hemerion.com\\\/fr\\\/solutions-therapeutiques\\\/cancer-du-cerveau-et-glioblastome\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/solutions-therapeutiques\\\/cancer-du-cerveau-et-glioblastome\\\/#primaryimage\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/hemerion.com\\\/wp-content\\\/uploads\\\/medical-imaging.jpg?fit=2000%2C680&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/hemerion.com\\\/wp-content\\\/uploads\\\/medical-imaging.jpg?fit=2000%2C680&ssl=1\",\"width\":2000,\"height\":680,\"caption\":\"Image m\u00e9dicale du cerveau\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/solutions-therapeutiques\\\/cancer-du-cerveau-et-glioblastome\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Solutions Th\u00e9rapeutiques\",\"item\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/solutions-therapeutiques\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Cancer du Cerveau et Glioblastome\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/\",\"name\":\"Hemerion\",\"description\":\"Advancing cancer therapies at the speed of light\",\"publisher\":{\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/#organization\",\"name\":\"Hemerion\",\"url\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/hemerion.com\\\/wp-content\\\/uploads\\\/hemerion-logo.png?fit=1581%2C460&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/hemerion.com\\\/wp-content\\\/uploads\\\/hemerion-logo.png?fit=1581%2C460&ssl=1\",\"width\":1581,\"height\":460,\"caption\":\"Hemerion\"},\"image\":{\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/HemerionTx\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/hemerion-therapeutics\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCWwcUj-aSdo32OYwN5vjf8Q\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cancer du Cerveau et Glioblastome","description":"Le glioblastome est le cancer le plus fr\u00e9quent et le plus agressif. Les traitements actuels ne font que ralentir la progression de la maladie.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/hemerion.com\/fr\/solutions-therapeutiques\/cancer-du-cerveau-et-glioblastome\/","og_locale":"fr_FR","og_type":"article","og_title":"Cancer du Cerveau et Glioblastome","og_description":"Le glioblastome est le cancer le plus fr\u00e9quent et le plus agressif. Les traitements actuels ne font que ralentir la progression de la maladie.","og_url":"https:\/\/hemerion.com\/fr\/solutions-therapeutiques\/cancer-du-cerveau-et-glioblastome\/","og_site_name":"Hemerion","article_modified_time":"2025-11-04T14:02:26+00:00","og_image":[{"width":2000,"height":680,"url":"https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/medical-imaging.jpg?fit=2000%2C680&ssl=1","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@HemerionTx","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/hemerion.com\/fr\/solutions-therapeutiques\/cancer-du-cerveau-et-glioblastome\/","url":"https:\/\/hemerion.com\/fr\/solutions-therapeutiques\/cancer-du-cerveau-et-glioblastome\/","name":"Cancer du Cerveau et Glioblastome","isPartOf":{"@id":"https:\/\/hemerion.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/hemerion.com\/fr\/solutions-therapeutiques\/cancer-du-cerveau-et-glioblastome\/#primaryimage"},"image":{"@id":"https:\/\/hemerion.com\/fr\/solutions-therapeutiques\/cancer-du-cerveau-et-glioblastome\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/medical-imaging.jpg?fit=2000%2C680&ssl=1","datePublished":"2021-06-21T14:07:47+00:00","dateModified":"2025-11-04T14:02:26+00:00","description":"Le glioblastome est le cancer le plus fr\u00e9quent et le plus agressif. Les traitements actuels ne font que ralentir la progression de la maladie.","breadcrumb":{"@id":"https:\/\/hemerion.com\/fr\/solutions-therapeutiques\/cancer-du-cerveau-et-glioblastome\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/hemerion.com\/fr\/solutions-therapeutiques\/cancer-du-cerveau-et-glioblastome\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/hemerion.com\/fr\/solutions-therapeutiques\/cancer-du-cerveau-et-glioblastome\/#primaryimage","url":"https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/medical-imaging.jpg?fit=2000%2C680&ssl=1","contentUrl":"https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/medical-imaging.jpg?fit=2000%2C680&ssl=1","width":2000,"height":680,"caption":"Image m\u00e9dicale du cerveau"},{"@type":"BreadcrumbList","@id":"https:\/\/hemerion.com\/fr\/solutions-therapeutiques\/cancer-du-cerveau-et-glioblastome\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/hemerion.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Solutions Th\u00e9rapeutiques","item":"https:\/\/hemerion.com\/fr\/solutions-therapeutiques\/"},{"@type":"ListItem","position":3,"name":"Cancer du Cerveau et Glioblastome"}]},{"@type":"WebSite","@id":"https:\/\/hemerion.com\/fr\/#website","url":"https:\/\/hemerion.com\/fr\/","name":"Hemerion","description":"Advancing cancer therapies at the speed of light","publisher":{"@id":"https:\/\/hemerion.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/hemerion.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/hemerion.com\/fr\/#organization","name":"Hemerion","url":"https:\/\/hemerion.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/hemerion.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/hemerion-logo.png?fit=1581%2C460&ssl=1","contentUrl":"https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/hemerion-logo.png?fit=1581%2C460&ssl=1","width":1581,"height":460,"caption":"Hemerion"},"image":{"@id":"https:\/\/hemerion.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/HemerionTx","https:\/\/www.linkedin.com\/company\/hemerion-therapeutics\/","https:\/\/www.youtube.com\/channel\/UCWwcUj-aSdo32OYwN5vjf8Q"]}]}},"jetpack_shortlink":"https:\/\/wp.me\/Pd9WhZ-ot","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/hemerion.com\/fr\/wp-json\/wp\/v2\/pages\/1517","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hemerion.com\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/hemerion.com\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/hemerion.com\/fr\/wp-json\/wp\/v2\/users\/207845438"}],"replies":[{"embeddable":true,"href":"https:\/\/hemerion.com\/fr\/wp-json\/wp\/v2\/comments?post=1517"}],"version-history":[{"count":32,"href":"https:\/\/hemerion.com\/fr\/wp-json\/wp\/v2\/pages\/1517\/revisions"}],"predecessor-version":[{"id":8441,"href":"https:\/\/hemerion.com\/fr\/wp-json\/wp\/v2\/pages\/1517\/revisions\/8441"}],"up":[{"embeddable":true,"href":"https:\/\/hemerion.com\/fr\/wp-json\/wp\/v2\/pages\/1501"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/hemerion.com\/fr\/wp-json\/wp\/v2\/media\/1321"}],"wp:attachment":[{"href":"https:\/\/hemerion.com\/fr\/wp-json\/wp\/v2\/media?parent=1517"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}